Article: FDA: BYETTA LABEL REVISED TO INCLUDE SAFETY INFORMATION ON POSSIBLE KIDNEY PROBLEMS

Article: BYETTA(R) Shown to Reduce Blood Glucose Levels When Added ...
PR Newswire;  June 10, 2006 ;     700+ words ... ... with or without metformin. Patients using BYETTA showed improvements in three ... in average body weight. BYETTA-treated patients lost an average of approximately ... At the end of the study, patients on BYETTA experienced an average reduction ...

Article: BYETTA Shown to Reduce Blood Sugar Levels When Added to ...
PR Newswire;  November 15, 2005 ;     700+ words ... ... exenatide) injection BYETTA (exenatide) injection ... blood sugar control in patients with type 2 diabetes ... substitute for insulin in patients whose diabetes requires insulin treatment. BYETTA is not recommended for use in patients with severe problems ...

Article: Diabetes Drug Byetta May Aid Weight Loss in Obese ...
Consumer Health News (English);  June 11, 2009 ;     700+ words ... ... Reporter THURSDAY, June 11 (HealthDay News) -- Exenatide (Byetta), a drug normally used to treat diabetes, may also help non ... Pharmaceuticals and Eli Lilly and Company under the brand name Byetta, can help lower blood sugar and helps some diabetics lose weight ...

Article: First Reported Head-to-Head Study Showed BYETTA[R] ...
Medical Letter on the CDC & FDA;  October 12, 2008 ;     700+ words ... ... to moderate nausea (BYETTA: 34 percent vs. Januvia ... percent) and vomiting (BYETTA: 24 percent vs. Januvia ... was reported in a patient treated with BYETTA. Study Design and Population ... week study evaluated patients with type 2 diabetes ...

Article: First Reported Head-to-Head Study Showed BYETTA(R) ...
PR Newswire;  September 9, 2008 ;     700+ words ... ... to moderate nausea (BYETTA: 34 percent vs. Januvia ... percent) and vomiting (BYETTA: 24 percent vs. Januvia ... was reported in a patient treated with BYETTA. Study Design and Population ... week study evaluated patients with type 2 diabetes ...

Article: BYETTA(R) - First in a New Class of Medicines for ...
PR Newswire Europe;  July 10, 2007 ;     700+ words ... ... potential benefit to patients has been recognised by the SMC." BYETTA is the first in ... pancreas and brain. BYETTA is approved in the ... sugar control in patients with type 2 diabetes ... medications.(4) BYETTA provides sustained ... comparator studies, patients initiating exenatide ...

Article: Amylin Pharmaceuticals Inc's (San Diego CA) diabetes treatment ...
MondayMorning;  September 15, 2008 ;     700+ words ... ... shares were battered last month after six patients taking Byetta died with an inflamed pancreas. Patients with diabetes have an increased risk ... risks, and ease of use of each drug. Patients taking Byetta were more likely to feel nauseated ...